Publication | Closed Access

Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer

Decreased Erlotinib EfficacyNon–small-cell Lung CancerOncologyGastrointestinal OncologyMedicinePathologyBronchial NeoplasmPharmacologyLung CancerCancer Research